SCHEMBL22945378

SCHEMBL22945378

CC(C)(C)OC(=O)N1CCC=C(C2CCCCCCC2)C1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.47
HPGD P15428 1/20 0.46
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
THRB P10828 1/20 0.43
PDE4B Q07343 1/20 0.43
ABL1 P00519 1/20 0.43
RIN1 Q13671 1/20 0.43
GPR119 Q8TDV5 5/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
ESR2 Q92731 1/20 0.41
MAPK1 P28482 1/20 0.40
PTPN2 P17706 1/20 0.40
PTPN1 P18031 1/20 0.40
PTPN6 P29350 1/20 0.40
NR1H2 P55055 1/20 0.40
NAMPT P43490 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25048929 0.99 EPHX1 (0.45) EPHX1HPGDMAPTKDM4ETHRB
SCHEMBL29594057 0.93 KDM4E (0.46) HPGDMAPTKDM4ETHRBGPR119
SCHEMBL5063459 0.89 MAPT (0.49) EPHX1HPGDMAPTKDM4ETHRB
SCHEMBL25048593 0.85 KDM4E (0.43) MAPTKDM4ETHRBGPR119KMT2A
SCHEMBL18615255 0.84 PDE4B (0.41) EPHX1HPGDMAPTKDM4ETHRB
SCHEMBL19502935 0.83 PDE4B (0.42) EPHX1HPGDMAPTKDM4ETHRB
SCHEMBL23384723 0.78 TNK2 (0.48) EPHX1HPGDMAPTKDM4ETHRB
SCHEMBL19703121 0.78 TNK2 (0.48) EPHX1HPGDMAPTKDM4ETHRB
SCHEMBL18556946 0.76 ESR2 (0.50) MAPTKDM4ETHRBGPR119KMT2A
SCHEMBL12519920 0.76 ESR2 (0.47) MAPTKDM4ETHRBGPR119KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11345679-B2 Quaternary lactam compound and pharmaceutical use thereof SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO., LTD. (CN) 2022-05-31 US disclosed
US-20210032219-A1 QUATERNARY LACTAM COMPOUND AND PHARMACEUTICAL USE THEREOF SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO., LTD. (CN) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210032219-A1 QUATERNARY LACTAM COMPOUND AND PHARMACEUTICAL USE THEREOF F2, PCSK9, F9 EPHX1 1678/4885HPGD 1178/4885MAPT 3249/4885
US-11345679-B2 Quaternary lactam compound and pharmaceutical use thereof F2, PCSK9, F9 EPHX1 1678/4885HPGD 1178/4885MAPT 3249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.